A chiral catalyst represented by formula (II) is provided. In formula (II), Y independently includes hydrogen, fluorine, trifluoromethyl, isopropyl, tert-butyl, C.sub.mH.sub.2m+1 or OC.sub.mH.sub.2m+1, wherein m=1-10 and n=1-10. A heterogeneous chiral catalyst is also provided. The heterogeneous chiral catalyst includes the chiral catalyst represented by formula (II), and a substrate connected to the chiral catalyst. ##STR00001##

A chiral catalyst represented by formula (II) is provided. In formula (II), Y independently includes hydrogen, fluorine, trifluoromethyl, isopropyl, tert-butyl, C.sub.mH.sub.2m+1 or OC.sub.mH.sub.2m+1, wherein m=1-10 and n=1-10. A heterogeneous chiral catalyst is also provided. The heterogeneous chiral catalyst includes the chiral catalyst represented by formula (II), and a substrate connected to the chiral catalyst.

##STR00001##

A chiral catalyst represented by formula (I) is provided. In formula (I), Z═Z.sub.1 or Z.sub.2, and the combination of Z.sub.1 and Z.sub.2 in formula (I) includes

##STR00001##

Y independently includes hydrogen, fluorine, trifluoromethyl, isopropyl, tert-butyl, C.sub.mH.sub.2m+1 or OC.sub.mH.sub.2m+1, m=1-10, and n=1-10. A heterogeneous chiral catalyst including the chiral catalyst is also provided.

##STR00002##

Cationic silicon (ii) compounds are easily formed by reaction of π-bonded cyclopentadienyl silicon (II) compound with a carbo-cation. The compounds have catalytic uses, particularly as a hydrosilylation catalyst.

The present invention discloses in situ generated catalyst bound alpha radical compound represented by formula (I) or (II) and a single pot process for the preparation of oxo compounds by using in situ generated catalyst bound alpha radical compound of formula (I) or (II).

Provided herein are diaryl and arylalkyl phosphonates, useful as intermediates in, for example, the synthesis of leukocyte elastase inhibitors, potassium channel modulators, chemiluminescence materials, and flame retardants, and methods for making same. Also provided are N-heterocyclic phosphorodiamidic acids (NHPAs) useful in reactions such as, for example, in the preparation of diaryl and arylalkyl phosphonates. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

The invention describes the process of catalytic O-demethylation of 3-methoxymorphinane compounds using boron tribromide. Addition of catalysts reduces the reaction time, improves reacting the substrate to give the product in very good purity and yield. The process can be used, for example, for the preparation of oxycodone, oxymorphone, naltrexone, naloxone and nalbuphine from their respective O-methyl derivatives.

This invention is related to the synthesis of organic carbonates from carbon dioxide and epoxides. It is particularly focused on the production of propylene cyclic carbonate from propylene oxide. The proposed catalytic materials includes a support made of aluminum oxyhydroxide (Catapal B®), nitric acid, acetic acid and/or phosphoric acid. An important stage is the physical and chemical conditioning of the catalytic materials and to this end, experimental methodologies such as spheronization and thermal treatments were implemented prior the evaluation process.

The present invention provides a method of preparing a heterogeneous linear carbonate, the method including transesterifying an aliphatic alcohol and a symmetric linear carbonate in the presence of a catalyst, wherein the catalyst is an acidic ion exchange resin, and a mass ratio of the aliphatic alcohol and the symmetric linear carbonate (aliphatic alcohol:symmetric linear carbonate) is 1:10 or more and 50:1 or less. The preparation method of the present specification provides a method of preparing a heterogeneous, symmetric linear carbonate and asymmetric linear carbonate in high yield without a process of reactive distillation, and is economical because a product and a catalyst can be easily separated.

The present invention relates to a method for the preparation of faujasite nanocrystals, to faujasite nanocrystals, to a method for the preparation of a stable colloidal suspension of faujasite nanocrystals, to a stable colloidal suspension of faujasite nanocrystals, and to the use of said faujasite nanocrystals and said stable colloidal suspension of faujasite nanocrystals in various applications.